Barely Significant
← all excerpts

Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings.

Diagnostics (Basel) · 2023 · PMC9954913 · PMID 36832164

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

highly significantno p-value reported
In this review, we highlighted key circulating blood- or urine-based HCC biomarkers and considered their potential applications in resource-limited settings, where the unmet medical needs of HCC are disproportionately highly significant. hepatocellular carcinoma liver cancer early detection circulating biomarkers resource-limited settings low-to-middle-income countries (LMICs) Center of Excellence for Liver Disease in Vietnam, Johns Hopkins University School of Medicine 800515555 This work was supported by the Center of Excellence

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.